Results 201 to 210 of about 19,507 (228)

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients

Modern Rheumatology, 2014
Naoki Ishiguro, Tsutomu Takeuchi, Hisashi Yamanaka   +2 more
exaly  

Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China

New England Journal of Medicine, 2011
Bao-Ping Zhu
exaly  

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients

Modern Rheumatology, 2012
Masayoshi Harigai, Naoki Ishiguro, Tsutomu Takeuchi   +2 more
exaly  

Postmarketing Surveillance

2003
openaire   +1 more source

Postmarketing drug surveillance studies

Clinical Pharmacology and Therapeutics, 1991
openaire   +2 more sources

Rivaroxaban postmarketing risk of liver injury

Journal of Hepatology, 2014
Stefan Russmann, Bruno Stieger, Gerd A Kullak-Ublick   +2 more
exaly  

Postmarket Surveillance

2013
openaire   +1 more source

Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources

Seminars in Arthritis and Rheumatism, 2015
Jeffrey R Curtis, Susanna Perez-Gutthann, Samy Suissa   +2 more
exaly  

Postmarketing Adverse Events Related to the CardioMEMS HF System

JAMA Cardiology, 2017
Ersilia M Defilippis, Javed Butler
exaly  

Postmarketing Surveillance

2007
openaire   +1 more source